Search Results - "Nosaka, Emi"
-
1
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor
Published in Cancer science (01-10-2017)“…Polycomb repressive complex 2 (PRC2) methylates histone H3 lysine 27 and represses gene expression to regulate cell proliferation and differentiation. Enhancer…”
Get full text
Journal Article -
2
RS-1748, a Novel CC Chemokine Receptor 4 Antagonist, Inhibits Ovalbumin-Induced Airway Inflammation in Guinea Pigs
Published in Biological & Pharmaceutical Bulletin (2010)“…CC chemokine receptor 4 (CCR4) is generally recognized as a preferential marker for T helper 2 cells, and we have previously reported morpholine-derivative…”
Get full text
Journal Article -
3
Novel triple neurokinin receptor antagonist CS-003 inhibits respiratory disease models in guinea pigs
Published in European journal of pharmacology (31-10-2008)“…Neurokinins are known to induce neurogenic inflammation related to respiratory diseases. The effects of CS-003 ([1-{2-[(…”
Get full text
Journal Article -
4
Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses
Published in European journal of pharmacology (31-05-2008)“…Neurokinins are known to induce neurogenic inflammation related to respiratory diseases, though there is little information on triple neurokinin receptor…”
Get full text
Journal Article -
5
EZH1/2 Dual Inhibitor Valemetostat Tosylate (DS-3201b) Acts Differently from EZH2 Selective Inhibitor on Epigenetic Landscape to Exert Greater Anti-Tumor Effect Against Diffuse Large B-Cell Lymphoma
Published in Blood (23-11-2021)“…Enhancer of zeste homologous (EZH) 2 and its close homolog EZH1 are catalytic subunits of polycomb repressive complex (PRC) 2 protein complex, and play…”
Get full text
Journal Article -
6
Involvement of enhanced neurokinin NK3 receptor expression in the severe asthma guinea pig model
Published in European journal of pharmacology (01-09-2004)Get full text
Journal Article -
7
Anti-Tumor Effect of the EZH1/2 Dual Inhibitor Valemetostat Against Diffuse Large B-Cell Lymphoma Via Modulation of B-Cell Receptor Signaling and c-Myc Signaling Pathways
Published in Blood (13-11-2019)“…Enhancer of zeste homolog (EZH) 1 and its close homolog EZH2 are component of polycomb repressive complex 2 (PRC2), and play a partially redundant and crucial…”
Get full text
Journal Article -
8
Development and Characterization of the Novel Orally Bioavailable EZH1/2 Dual Inhibitor DS-3201
Published in Blood (08-12-2017)“…Polycomb repressive complex 2 (PRC2) methylates histone H3 lysine 27 (H3K27) and represses gene expression to regulate cell proliferation and differentiation…”
Get full text
Journal Article -
9
DS-3201, a Potent EZH1/2 Dual Inhibitor, Demonstrates Antitumor Activity Against Non-Hodgkin Lymphoma (NHL) Regardless of EZH2 Mutation
Published in Blood (29-11-2018)“…Enhancer of zests homologous (EZH)1 and its close homolog EZH2 are component of polycomb repressive complex (PRC) 2 protein complex, and play redundant and…”
Get full text
Journal Article -
10
Involvement of enhanced neurokinin NK 3 receptor expression in the severe asthma guinea pig model
Published in European journal of pharmacology (13-09-2004)“…In this study, we investigated the involvement of neurokinin NK 3 receptors in a severe asthma model prepared by administering ovalbumin via inhalation three…”
Get full text
Journal Article -
11
Involvement of enhanced neurokinin NK3 receptor expression in the severe asthma guinea pig model
Published in European journal of pharmacology (13-09-2004)“…In this study, we investigated the involvement of neurokinin NK3 receptors in a severe asthma model prepared by administering ovalbumin via inhalation three…”
Get full text
Journal Article -
12
Greater involvement of neurokinins found in Guinea pig models of severe asthma compared with mild asthma
Published in International archives of allergy and immunology (01-08-2004)“…Involvement of neurokinins in asthma has been previously pointed out by several reports. However, the relationship between neurokinins and the severity of…”
Get more information
Journal Article -
13
O-279 - Pharmacological activities of R-113281, a novel NK1, NK2 and NK3 receptor antagonist in vivo
Published in Japanese journal of pharmacology (2000)Get full text
Journal Article -
14
Pharmacological activities of R-113281, a novel NK1, NK2 and NK3 receptor antagonist in vivo
Published in Japanese journal of pharmacology (2000)Get full text
Journal Article